4//SEC Filing
Kaufman Jonathan H 4
Accession 0001753926-24-002182
CIK 0001347242other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 9:28 PM ET
Size
65.2 KB
Accession
0001753926-24-002182
Insider Transaction Report
Form 4
Kaufman Jonathan H
DirectorSee remarks below.10% Owner
Transactions
- Other
Common Stock Purchase Warrants
2024-12-23+85,421→ 85,421 total(indirect: By Self as proxy and power of attorney for Spartan)Exercise: $1.00From: 2024-12-27Exp: 2029-12-27→ Common Stock (85,421 underlying) - Other
Series C Voting Convertible Preferred Stock
2024-12-23+260,108→ 260,108 total(indirect: By Self as proxy and power of attorney for Spartan (as defined below))Exercise: $1.00→ Common Stock (260,108 underlying)
Footnotes (3)
- [F1]Such Series C Voting Convertible Preferred Stock, par value $0.0001 per share ("Preferred Stock"), common stock purchase warrants ("Warrants"), and the common stock, par value $0.0001 per share, of the issuer ("Common Stock"), issuable upon conversion of Preferred Stock ("Conversion Shares") and exercise of Warrants (the "Warrant Shares", and collectively with the Preferred Stock, Warrants and Conversion Shares, "Securities") are subject to an irrevocable proxy and power of attorney, effective December 20, 2024, between the reporting person and Spartan Capital Securities, LLC ("Spartan"), pursuant to which the reporting person has voting power over all Securities held by Spartan and its Affiliates (defined under Rule 405 of the Securities Act of 1933, as amended) or any person or entity acting as a group therewith ("Proxy and POA"). The reporting person disclaims beneficial ownership of the Securities except to the extent of his pecuniary interest therein, if any.
- [F2]Each share of Preferred Stock is convertible into shares of Common Stock on or after the date on which the registration statement filed by the issuer registering the reoffer and resale of the Conversion Shares has been declared effective by the U.S. Securities Exchange Commission.
- [F3]The conversion rights of the Preferred Stock do not expire.
Documents
Issuer
LIPELLA PHARMACEUTICALS INC.
CIK 0001347242
Entity typeother
Related Parties
1- filerCIK 0001959250
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 9:28 PM ET
- Size
- 65.2 KB